IRIS
MIKULSKA, MALGORZATA KAROLINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.387
Totale 12.387
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 12.387
Totale 12.387
Salva come PNG Salva come JPEG
Città #
Genova 8.772
Genoa 1.798
Rapallo 1.615
Vado Ligure 125
Bordighera 77
Totale 12.387
Salva come PNG Salva come JPEG
Nome #
Primary prophylaxis of invasive fungal diseases in allogeneic stem cell transplantation: revised recommendations from a consensus process by Gruppo Italiano Trapianto Midollo Osseo (GITMO). 171
Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit 168
Initial serum (1,3)-β-d-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil 159
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 149
Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir. 148
Bacterial infections in hematopoietic stem cell transplantation recipients. 135
Invasive candidiasis in non-hematological patients. 133
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an Infectious Diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52) 133
Effectiveness of a project to prevent HIV vertical transmission in the Republic of Congo. 132
Non-cultural methods for the diagnosis of invasive fungal disease 131
Pulmonary cryptococcosis with severe eosinophilia in an immunocompetent patient. 128
Pathogens in Severe Sepsis: New Paradigms for Fungi Treatment 125
Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome. 123
European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. 121
Risk factors for severe complications of the novel influenza A (H1N1): analysis of patients hospitalized in Italy. 121
Use of colistin in adult patients: a cross-sectional study 121
Invasive mycoses in children receiving hemopoietic SCT 120
Will new antimicrobials overcome resistance among Gram-negatives? 119
Mortality after bloodstream infections in allogeneichaematopoietic stem cell transplant (HSCT) recipients 119
Invasive pulmonary aspergillosis in intensive care units: is it a real problem? 115
Occurrence, presentation and treatment of candidemia. 115
SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients. 114
Biomarkers for Diagnosis and Follow-Up of Invasive Candidiasis: A Brief Review of the ECIL Recommendations 113
Lower sensitivity of serum (1,3)-β-D-glucan for the diagnosis of candidaemia due to Candida parapsilosis 113
Piperacillin/tazobactam (TazocinTM) seems to be no longer responsible forfalse-positive results of the galactomannan assay 113
Voriconazole in clinical practice. 112
Bacterial infections in hematopoietic stem cell transplant recipients 111
ECILrecommendations for the use of biological markers for the diagnosis of invasivefungal diseases in leukemic patients and hematopoietic SCT recipients 110
Galactomannan: testing the same sample twice? 110
Outbreak of Ralstonia pickettii bacteraemia in patients with haematological malignancies and haematopoietic stem cell transplant recipients 109
The Beta-d-glucan Test: Time to Re-Visit Its Utility in IFI Diagnosis 108
Performance of serum (1,3)-ß-d-glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies 108
CMV infection after transplant from cord blood compared to other alternative donors: the importance of donor-negative CMV serostatus. 108
De-Escalation and Discontinuation of Empirical Antibiotic Treatment in a Cohort of Allogeneic Hematopoietic Stem Cell Transplantation Recipients during the Pre-Engraftment Period 107
Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab 106
Current research in empirical therapy for febrile neutropenia in cancer patients: what should be necessary and what is going on. 105
Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy 105
Multidrug-resistant bacteria in hematology patients: Emerging threats 105
Screening With Serum Galactomannan Might Be Associated With Better Outcome Than Symptom-Triggered Galactomannan Testing in Allogeneic HSCT Recipients With Invasive Aspergillosis. 104
null 102
Enterococcal bloodstream infection after hematopoietic stem cell transplant: experience of a center with a low prevalence of vancomycin-resistant enterococci. 102
Discontinuation of empirical antibiotic therapy in neutropenic leukaemia patients with fever of unknown origin is ethical 102
La Definizione di Aspergillosi 101
Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients. 100
Invasive aspergillosis: diagnosis, prophylaxis and treatment 98
Clinical performance of the (1,3)-β-D-glucan assay in early diagnosis of nosocomial Candida bloodstream infections. 98
Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients. 97
Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance. 97
Epidemiology of viral respiratory tract infections in an outpatient haematology facility 97
Desirability of outcome ranking (DOOR) for comparing diagnostic tools and early therapeutic choices in patients with suspected candidemia 97
Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMT 96
Serum sickness (Like Reaction) in a patient treated with alemtuzumab for multiple sclerosis: A case report 96
Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients 96
Galactomannan testing might be useful for early diagnosis of fusariosis. 95
Visceral leishmaniasis in hematopoietic cell transplantation: Case report and review of the literature 95
Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011). 94
Efficacy of daptomycin lock therapy in the treatment of bloodstream infections related to long-term catheter. 94
Evaluation of mass spectrometry-based detection of panfungal serum disaccharide for diagnosis of invasive fungal infections: Results from a collaborative study involving six European clinical centers 93
Management of chronic viral hepatitis in the hematological patient 93
Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor 92
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens [II]: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4) 92
(1-3)-β-d-glucan in cerebrospinal fluid is useful for the diagnosis of central nervous system fungal infections. 92
Current and emerging pharmacotherapy for the treatment of infections following open-heart surgery 92
Why is community-associated MRSA spreading across the world and how will it change clinical practice? 90
Bloodstream infections in neutropenic cancer patients: A practical update 90
Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7) 90
Current role of echinocandins in the management ofinvasive aspergillosis 89
European survey on principles of prudent antibiotic prescribing teaching in undergraduate students 89
New treatment options against gram-negative organisms. 88
No report on Zika virus infection in EBMT registry: Infectious Diseases Working Party statement 87
Protective environment for hematopoietic cell transplant (HSCT) recipients: The Infectious Diseases Working Party EBMT analysis of global recommendations on health-care facilities 85
Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): Study protocol of a retrospective multicentre international study 83
Fluoroquinolone prophylaxis during neutropenia: what can we expect nowadays? 82
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 82
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact 81
Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS 81
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 81
2017 ECIL 7 vaccine guidelines 80
Bloodstream infections in critically ill patients with COVID-19 80
Manuale per la gestione delle complicanze infettive nell’emato-oncologia e trapianto di midollo osseo 78
Combined use of serum (1,3)-β-d-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 78
Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients 76
The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia. 76
Safety and efficacy of pegylated interferon and ribavirin in adolescents with human immunodeficiency virus and hepatitis C virus acquired perinatally. 75
Community associated methicillin resistant staphylococcus aureus (CA-MRSA) infective endocarditis in Italy. 74
ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients 73
Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines 73
Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation—a position paper 73
Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7) 73
The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT 72
ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients 71
Long course of daptomycin in the treatment of meticillin-resistant Staphylococcus epidermis endocarditis and spondylodiscitis 71
Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy 71
Pneumocystis jirovecii pneumonia: Still a concern in patients with haematological malignancies and stem cell transplant recipients 70
The european hematology association roadmap for european hematology research: A consensus document 70
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 70
Recent advances in the pharmacological management of infections due to multidrug-resistant Gram-negative bacteria 67
Management of adenovirus infection in patients after haematopoietic stem cell transplantation: State-of-the-art and real-life current approach: A position statement on behalf of the Infectious Diseases Working Party of the European Society of Blood and Marrow Transplantation 67
Correction to: Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy (Infection, 10.1007/s15010-017-1063-7) 67
Prophylaxis and Empirical Therapy of Infection in Cancer Patients 66
Totale 9.927
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.797
article - articoli 45.321
book - libri 236
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.240
Totale 93.594
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.203 0 87 110 213 333 391 487 313 347 507 300 115
2020/20211.484 80 103 80 102 87 81 185 198 133 187 122 126
2021/20221.741 67 48 101 233 75 168 77 414 86 179 70 223
2022/20232.087 194 139 27 184 265 286 72 138 306 132 279 65
2023/20241.482 82 168 55 190 158 217 84 107 72 47 120 182
2024/2025174 102 72 0 0 0 0 0 0 0 0 0 0
Totale 12.808